Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.27B | 6.27B | 6.22B | 6.34B | 6.50B | 7.52B |
Gross Profit | 3.16B | 3.22B | 3.10B | 2.82B | 3.07B | 3.95B |
EBITDA | 689.50M | 860.30M | 601.23M | 619.28M | 346.77M | 1.29B |
Net Income | 124.20M | 234.67M | 116.37M | 45.72M | -158.75M | 548.35M |
Balance Sheet | ||||||
Total Assets | 6.08B | 5.65B | 5.64B | 5.85B | 6.81B | 7.28B |
Cash, Cash Equivalents and Short-Term Investments | 1.34B | 1.27B | 794.45M | 555.29M | 621.86M | 970.52M |
Total Debt | 685.58M | 563.65M | 558.85M | 660.87M | 677.59M | 335.74M |
Total Liabilities | 2.81B | 2.47B | 2.52B | 2.75B | 3.24B | 3.32B |
Stockholders Equity | 3.16B | 3.08B | 3.00B | 2.98B | 3.26B | 3.62B |
Cash Flow | ||||||
Free Cash Flow | 681.26M | 734.33M | 644.25M | 300.21M | -295.70M | 617.89M |
Operating Cash Flow | 824.07M | 859.02M | 790.54M | 487.68M | 113.17M | 1.26B |
Investing Cash Flow | -148.48M | 65.89M | -317.52M | -481.79M | -405.82M | -641.86M |
Financing Cash Flow | -65.07M | -298.24M | -403.49M | -58.95M | -68.05M | -548.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | $9.98B | 42.42 | 7.71% | 1.11% | 0.91% | 101.66% | |
63 Neutral | $21.01B | 14.53 | -7.26% | 3.13% | 3.36% | -7.91% | |
― | $964.65M | 20.91 | -0.91% | 3.56% | ― | ― | |
71 Outperform | HK$7.23B | 37.46 | 5.15% | 1.39% | 3.95% | -42.81% | |
71 Outperform | HK$13.01B | 16.23 | 15.77% | 5.46% | 4.68% | -14.34% | |
67 Neutral | HK$14.34B | 36.79 | 2.35% | ― | ― | ||
62 Neutral | HK$8.48B | 14.52 | 5.82% | ― | 38.41% | ― |
Vitasoy International Holdings Ltd. has announced its upcoming Annual General Meeting (AGM) scheduled for August 25, 2025, where key agenda items include the adoption of financial statements, approval of a final dividend, re-election of directors, and appointment of auditors. Additionally, the company seeks shareholder approval for general mandates to issue and buy-back shares, which could influence its capital structure and market operations.
The most recent analyst rating on (HK:0345) stock is a Buy with a HK$6.90 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.
Vitasoy International Holdings announced a supplemental update regarding the grant of share options and performance share units to its executives and employees. The grant includes 1,326,000 share options to the Executive Chairman, Mr. Winston Yau-lai Lo, which represents 0.12% of the company’s shares as of June 2025. This grant is subject to approval by independent shareholders at the 2025 AGM, as it exceeds the threshold set by the Listing Rules. The company plans to distribute a circular with more details to shareholders.
The most recent analyst rating on (HK:0345) stock is a Hold with a HK$6.00 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.
Vitasoy International Holdings Limited has announced the grant of share options and performance share units to eligible participants under its 2022 Share Option Scheme and 2021 Share Award Scheme. The initiative aims to recognize past individual performance and align participants’ interests with the company’s long-term success. The grant includes 4,912,000 share options at an exercise price of HK$9.25 per share, with a vesting period of four years. The move is designed to attract and retain key employees, offering competitive compensation and driving strategic goals.
The most recent analyst rating on (HK:0345) stock is a Hold with a HK$6.00 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.
Vitasoy International Holdings Limited announced a final ordinary cash dividend of HKD 0.102 per share for the financial year ending March 31, 2025. The dividend is set to be paid on September 17, 2025, following shareholder approval on August 25, 2025. This announcement reflects the company’s ongoing commitment to providing returns to its shareholders and may influence investor sentiment positively.
The most recent analyst rating on (HK:0345) stock is a Buy with a HK$6.90 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.
Vitasoy International Holdings Limited has announced proposed amendments to its Articles of Association to align with recent changes in the Companies Ordinance and the Listing Rules in Hong Kong. These amendments aim to implement a treasury share regime and promote paperless corporate communications, reflecting the company’s adaptation to regulatory updates and its commitment to modernizing its corporate governance practices.
The most recent analyst rating on (HK:0345) stock is a Buy with a HK$6.90 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.
Vitasoy International Holdings reported a 1% increase in revenue to HK$6,274 million for the year ended 31st March 2025, driven by growth in Mainland China and strong performance in Hong Kong. The company’s gross profit margin improved to 51.3% due to lower commodity costs and enhanced manufacturing efficiency, although this was partially offset by higher trade promotional expenses and unfavorable foreign exchange movements. Profit attributable to equity shareholders surged by 102%, reflecting improved sales execution and operational efficiency. The company also announced a significant increase in dividends, proposing a total of HK14.2 cents per ordinary share for FY2024/2025, up from HK7.7 cents in the previous year.
The most recent analyst rating on (HK:0345) stock is a Buy with a HK$6.90 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.
Vitasoy International Holdings Limited has announced a board meeting scheduled for June 24, 2025, to approve the final results for the fiscal year ending March 31, 2025, and to consider the payment of a final dividend. This meeting is significant as it will determine the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:0345) stock is a Buy with a HK$9.50 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.
Vitasoy International Holdings has issued a positive profit alert, indicating a substantial increase in profit attributable to shareholders for the financial year ending March 31, 2025. The expected profit range is between HK$225 million and HK$245 million, marking a 94% to 111% increase from the previous year. This growth is driven by improved operations in Mainland China and Hong Kong SAR, as well as reduced losses in Australia, despite higher tax expenses.
The most recent analyst rating on (HK:0345) stock is a Buy with a HK$9.50 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.